Cargando…
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
The world is grappling with an unprecedented public health crisis COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2. Due to the high transmission/mortality rates and socioeconomic impacts of the COVID-19, its control is crucial. In the absence of specific treatment, vaccines represent the...
Autores principales: | Jafari, Ameneh, Danesh Pouya, Fahima, Niknam, Zahra, Abdollahpour‑Alitappeh, Meghdad, Rezaei-Tavirani, Mostafa, Rasmi, Yousef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890022/ https://www.ncbi.nlm.nih.gov/pubmed/35235159 http://dx.doi.org/10.1007/s11033-022-07132-7 |
Ejemplares similares
-
Potential therapeutic options for COVID-19: an update on current evidence
por: Niknam, Zahra, et al.
Publicado: (2022) -
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
por: Farahani, Masoumeh, et al.
Publicado: (2022) -
Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
por: Li, Mengling, et al.
Publicado: (2021) -
Changes in incidence and mortality trend due to COVID-19 in southern Iran, from 2020 to 2021: based on Cochran–Armitage trend test
por: Rezaei, Behzad, et al.
Publicado: (2023) -
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020)